Valeant Tells Full Fed. Circ. Relistor Patent Ruling Is 'Alarming'
Valeant Pharmaceuticals has asked the full Federal Circuit to rehear a panel decision that vacated its win against Mylan Pharmaceuticals in a fight over a patent covering the opioid-induced constipation drug...To view the full article, register now.
Already a subscriber? Click here to view full article